Live·Verified funding discovery · 2026.2

874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640

△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA

Ratings

Eternal Search

Heroes

People whose work, funding, scientific leadership, and multiplier effects have shaped the longevity field.

Every score here rates one thing: longevity commitment. The role tags — scientist, investor, founder, and the rest — describe what a person does. We do not compute a separate rating for each tag.

Scoring AI engine · v0.9.0

RolesAll clinician communicator entrepreneur investor operator philanthropist populariser scientist self-experimenter

ThemesAll Destination Meta View Path Risk View Timeline

SortOverall Recently updated Future vision Scientific impact Capital deployed Strategic taste Field creation Bravery and conviction Multiplier effect

#ScoreHeroDimensionsScored

Aubrey de Greyv0.4.0

He made SENS-style damage repair a durable longevity agenda: 325 works, 4,733 citations, and public pushes for political attention. Not proof of therapies. Proof of agenda-setting.

populariserscientistphilanthropist

João Pedro de Magalhãesv0.4.0

Magalhães helped build aging biology’s plumbing: genomic and longevity databases that became highly cited tools, not just another pile of anti-aging slogans.

scientistentrepreneurphilanthropist

Steve Horvathv0.4.0

Horvath made aging measurable enough for others to argue with it. His epigenetic clocks became a test bed for longevity claims, including studies that find no rejuvenation when the hype fails.

scientistpopulariserphilanthropist

David Gobelv0.6.0

Gobel’s direct science record is thin. His real longevity impact is co-founding Methuselah Foundation, an early platform for prizes, grants, projects, and ventures chasing healthy lifespan.

philanthropistpopulariserentrepreneur

Michael Grevev0.6.0

Greve helped make longevity more operational: Forever Healthy pushes intervention reviews and translation of molecular repair research into therapies. The capital claims are thinner than the legend.

investorphilanthropistentrepreneur

Mehmood Khanv0.8.0

Khan pushed geroscience toward clinical translation by calling for new funding models and helping convene the 2023 Global Healthspan Summit.

philanthropistoperatorscientist

Jim Mellonv0.4.0

Mellon helped make longevity biotech legible as a company category, mainly through Juvenescence and field-definition papers. Scientific footprint: modest, not mythical.

entrepreneurinvestorphilanthropist

Martin Borch Jensenv0.4.0

Jensen helped make mitochondrial aging less hand-wavy: 76 works, 1,955 citations, and longevity org-building through Gordian and Norn. Real contribution, not life-extension magic.

entrepreneurphilanthropistpopulariser

Sergey Youngv0.4.0

Sergey Young helped put investor attention into longevity through Longevity Vision Fund and field-definition work. The record shows visibility, not proof of big deployed capital.

investorpopulariserphilanthropist

Yuri Milnerv0.4.0

Milner is weakly linked to Altos Labs, making his visible longevity impact a reported bet on cellular reprogramming rather than a proven field record. Thin evidence, so no victory lap.

philanthropistinvestorentrepreneur

Karl Pflegerv0.4.0

Pfleger helped make aging biotech more legible through AgingBiotech.info and coauthored a paper arguing that healthy life extension has far more public demand than sloppy surveys suggested.

populariserinvestorphilanthropist

Vitalik Buterinv0.4.0

The public record here does not prove a concrete longevity impact. At most, Buterin is weakly linked to longevity-adjacent funding, with no disclosed bets, gifts, or strategy.